One of Ten in the U.S. to Receive ASCO Clinical Trials Award for Improving Cancer Care
NEW ORLEANS - The Ochsner Cancer Institute is one of only 10 community oncology practices in the country to be for its efforts to improve cancer care through participation in clinical trials. Ochsner has been awarded the American Society of Clinical Oncology (ASCO) and The ASCO Cancer Foundation ASCO's 2008 Clinical Trial Participation Award which will be presented on June 1, 2008 at ASCO's 44th Annual Meeting in Chicago.
"Ochsner is honored to have been chosen for this award," said Dr. John Cole, MD, Head of Hematology/Oncology at Ochsner Medical Center. "Our patients are the real heroes by personally contributing to the progress being made against cancer through research. We are constantly working to improve access to clinical trials and Ochsner just announced a partnership with LSUHSC to combine the strengths of medical education, cancer research, and strong clinical cancer to better provide for the treatment of cancer patients in greater New Orleans."
Of the 1.3 million people who will be diagnosed with cancer this year, only 3 to 5 percent will participate in cancer clinical trials. Over the past 10 years, the Ochsner Cancer Institute has enrolled over 2,200 patients onto clinical trials. Currently, Ochsner has 103 active oncology trials which are actively enrolling patients or in the follow-up phase.
"Virtually every cancer treatment available today is the direct result of clinical research. ASCO is pleased to honor the Ochsner Cancer Institute for its dedication to developing new ways to slow, halt, cure and prevent cancer," said ASCO President Nancy Davidson, MD.
Clinical trials are research studies designed to evaluate whether a new treatment or procedure is safe and effective compared to the current standard of care. Thanks in large part to the knowledge gained through clinical trials, today two-thirds of cancer patients survive at least five years after diagnosis, compared with half in the 1970s.
This year's award winners were selected based on many factors, including patient accrual to clinical trials over a three-year period. In addition to being a national leader in providing patients access to clinical trials, Ochsner also offers cancer care and treatment from a team of dedicated professional staff with patient access to nutritional, counseling and psychosocial support services. "Ochsner's multi-disciplinary approach enables our patients and their families' immediate access to their medical needs in one location," says Cole.
For more information on participating in a clinical trial at Ochsner Medical Center, contact (504) 842-3708 or discuss with your personal physician.
Ochsner Health System (www.ochsner.org) is a non-profit, academic, multi-specialty, healthcare delivery system dedicated to patient care, research and education. The system includes seven hospitals and over 35 health centers located throughout Southeast Louisiana. Ochsner employs over 600 physicians in 80 medical specialties and subspecialties and 450 clinical research trials annually. Ochsner has over 10,000 employees system-wide.
The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 25,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit http://www.asco.org/presscenter. Patient-oriented cancer information is available at www.cancer.net.